Publicaciones en las que colabora con Camilo Silva Frojan (15)

2024

  1. FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233

2023

  1. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

  2. Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

    Metabolism: Clinical and Experimental, Vol. 147

2020

  1. Ghrelin Reduces TNF-α-Induced Human Hepatocyte Apoptosis, Autophagy, and Pyroptosis: Role in Obesity-Associated NAFLD

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 1, pp. 21-37

  2. Impact of Routine and Long-Term Follow-Up on Weight Loss after Bariatric Surgery

    Obesity Surgery, Vol. 30, Núm. 11, pp. 4293-4299

2018

  1. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities

    Clinical Nutrition, Vol. 37, Núm. 2, pp. 580-589

2016

  1. Does Preincisional Infiltration with Bupivacaine Reduce Postoperative Pain in Laparoscopic Bariatric Surgery?

    Obesity Surgery, Vol. 26, Núm. 2, pp. 282-288

  2. Increased interleukin-32 levels in obesity promote adipose tissue inflammation and extracellular matrix remodeling: Effect of weight loss

    Diabetes, Vol. 65, Núm. 12, pp. 3636-3648

2013

  1. Obstructive sleep apnea severity is associated with left ventricular mass independent of other cardiovascular risk factors in morbid obesity

    Journal of Clinical Sleep Medicine, Vol. 9, Núm. 11, pp. 1165-1171

2012

  1. Estudio de la utilidad de la bioimpedancia en la determinación de la grasa visceral y su aplicación en el diagnóstico y tratamiento de la obesidad y sus comorbilidades

    Anales del sistema sanitario de Navarra, Vol. 35, Núm. 1, pp. 183-184

  2. The ghrelin O-Acyltransferase-Ghrelin system reduces TNF-α-Induced apoptosis and autophagy in human visceral adipocytes

    Diabetologia, Vol. 55, Núm. 11, pp. 3038-3050

2010

  1. Association of plasma acylated ghrelin with blood pressure and left ventricular mass in patients with metabolic syndrome

    Journal of Hypertension, Vol. 28, Núm. 3, pp. 560-567

2009

  1. Acylated and desacyl ghrelin stimulate lipid accumulation in human visceral adipocytes

    International Journal of Obesity, Vol. 33, Núm. 5, pp. 541-552

  2. La actividad física determinada mediante acelerometría es menor en los pacientes obesos

    Trauma, Vol. 20, Núm. 2, pp. 83-91

2007

  1. Plasma osteopontin levels and expression in adipose tissue are increased in obesity

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 9, pp. 3719-3727